Seeking Alpha HealthcareOriginal article
Fulgent expects $330M-$340M 2026 revenue as billing transition lowers collection rates
EarningsNegative
AI Analysis
Summary
Fulgent Genetics provided 2026 revenue guidance of $330M-$340M, noting that a billing transition is expected to lower collection rates.
Financial Highlights
Revenue
$330M-$340M
Guidance
2026 revenue guidance of $330M-$340M
Importance:3/10
Sentiment:
-0.30
revenue guidancebilling transitioncollection rates2026 outlook
Related Companies
Read the original article
Published by Seeking Alpha Healthcare on July 31, 2026 12:24 PM